These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 34174057)

  • 1. Holmium-166 Microspheres are Visible in Target Liver Lesions on Unenhanced Computed Tomography.
    Bonne L; De Bondt P; Sermon F; Maleux G
    J Gastrointestin Liver Dis; 2021 Jun; 30(2):192. PubMed ID: 34174057
    [No Abstract]   [Full Text] [Related]  

  • 2. Holmium-166 Microsphere Radioembolization of Hepatic Malignancies.
    Reinders MTM; Smits MLJ; van Roekel C; Braat AJAT
    Semin Nucl Med; 2019 May; 49(3):237-243. PubMed ID: 30954190
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Microspheres with ultrahigh holmium content for radioablation of malignancies.
    Bult W; Seevinck PR; Krijger GC; Visser T; Kroon-Batenburg LM; Bakker CJ; Hennink WE; van het Schip AD; Nijsen JF
    Pharm Res; 2009 Jun; 26(6):1371-8. PubMed ID: 19240985
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy of Radioembolization with
    Prince JF; van den Bosch MAAJ; Nijsen JFW; Smits MLJ; van den Hoven AF; Nikolakopoulos S; Wessels FJ; Bruijnen RCG; Braat MNGJA; Zonnenberg BA; Lam MGEH
    J Nucl Med; 2018 Apr; 59(4):582-588. PubMed ID: 28916623
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical effects of transcatheter hepatic arterial embolization with holmium-166 poly(L-lactic acid) microspheres in healthy pigs.
    Vente MA; Nijsen JF; de Wit TC; Seppenwoolde JH; Krijger GC; Seevinck PR; Huisman A; Zonnenberg BA; van den Ingh TS; van het Schip AD
    Eur J Nucl Med Mol Imaging; 2008 Jul; 35(7):1259-71. PubMed ID: 18330569
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Influence of neutron irradiation on holmium acetylacetonate loaded poly(L-lactic acid) microspheres.
    Nijsen JF; van Het Schip AD; van Steenbergen MJ; Zielhuis SW; Kroon-Batenburg LM; van de Weert M; van Rijk PP; Hennink WE
    Biomaterials; 2002 Apr; 23(8):1831-9. PubMed ID: 11950053
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Safety of a Scout Dose Preceding Hepatic Radioembolization with 166Ho Microspheres.
    Prince JF; van Rooij R; Bol GH; de Jong HW; van den Bosch MA; Lam MG
    J Nucl Med; 2015 Jun; 56(6):817-23. PubMed ID: 25931477
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Magnetic resonance imaging-based radiation-absorbed dose estimation of 166Ho microspheres in liver radioembolization.
    Seevinck PR; van de Maat GH; de Wit TC; Vente MA; Nijsen JF; Bakker CJ
    Int J Radiat Oncol Biol Phys; 2012 Jul; 83(3):e437-44. PubMed ID: 22633554
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Targeting of liver tumour in rats by selective delivery of holmium-166 loaded microspheres: a biodistribution study.
    Nijsen F; Rook D; Brandt C; Meijer R; Dullens H; Zonnenberg B; de Klerk J; van Rijk P; Hennink W; van het Schip F
    Eur J Nucl Med; 2001 Jun; 28(6):743-9. PubMed ID: 11440035
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Radioembolization With Holmium-166 Polylactic Acid Microspheres: Distribution of Residual Activity in the Delivery Set and Outflow Dynamics During Planning and Treatment Procedures.
    Drescher R; Seifert P; Gühne F; Aschenbach R; Kühnel C; Freesmeyer M
    J Endovasc Ther; 2021 Jun; 28(3):452-462. PubMed ID: 33629598
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Holmium-166 poly lactic acid microspheres applicable for intra-arterial radionuclide therapy of hepatic malignancies: effects of preparation and neutron activation techniques.
    Nijsen JF; Zonnenberg BA; Woittiez JR; Rook DW; Swildens-van Woudenberg IA; van Rijk PP; van het Schip AD
    Eur J Nucl Med; 1999 Jul; 26(7):699-704. PubMed ID: 10398817
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 166Ho-microsphere liver radiotherapy: a preclinical SPECT dosimetry study in the pig.
    Turner JH; Claringbold PG; Klemp PF; Cameron PJ; Martindale AA; Glancy RJ; Norman PE; Hetherington EL; Najdovski L; Lambrecht RM
    Nucl Med Commun; 1994 Jul; 15(7):545-53. PubMed ID: 7970432
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Safety analysis of holmium-166 microsphere scout dose imaging during radioembolisation work-up: A cohort study.
    Braat AJAT; Prince JF; van Rooij R; Bruijnen RCG; van den Bosch MAAJ; Lam MGEH
    Eur Radiol; 2018 Mar; 28(3):920-928. PubMed ID: 28786008
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Quantitative dual-energy CT material decomposition of holmium microspheres: local concentration determination evaluated in phantoms and a rabbit tumor model.
    Gutjahr R; Bakker RC; Tiessens F; van Nimwegen SA; Schmidt B; Nijsen JFW
    Eur Radiol; 2021 Jan; 31(1):139-148. PubMed ID: 32767101
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characterization of poly(L-lactic acid) microspheres loaded with holmium acetylacetonate.
    Nijsen JF; van Steenbergen MJ; Kooijman H; Talsma H; Kroon-Batenburg LM; van De Weert M; van Rijk PP; De Witte A; Van Schip AD; Hennink WE
    Biomaterials; 2001 Nov; 22(22):3073-81. PubMed ID: 11575483
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Holmium-lipiodol-alginate microspheres for fluoroscopy-guided embolotherapy and multimodality imaging.
    Oerlemans C; Seevinck PR; Smits ML; Hennink WE; Bakker CJ; van den Bosch MA; Nijsen JF
    Int J Pharm; 2015 Mar; 482(1-2):47-53. PubMed ID: 25448561
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intratumoral administration of holmium-166 acetylacetonate microspheres: antitumor efficacy and feasibility of multimodality imaging in renal cancer.
    Bult W; Kroeze SG; Elschot M; Seevinck PR; Beekman FJ; de Jong HW; Uges DR; Kosterink JG; Luijten PR; Hennink WE; van het Schip AD; Bosch JL; Nijsen JF; Jans JJ
    PLoS One; 2013; 8(1):e52178. PubMed ID: 23320070
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Liver tumors: MR imaging of radioactive holmium microspheres--phantom and rabbit study.
    Nijsen JF; Seppenwoolde JH; Havenith T; Bos C; Bakker CJ; van het Schip AD
    Radiology; 2004 May; 231(2):491-9. PubMed ID: 15031432
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Holmium-166 radioembolization for the treatment of patients with liver metastases: design of the phase I HEPAR trial.
    Smits ML; Nijsen JF; van den Bosch MA; Lam MG; Vente MA; Huijbregts JE; van het Schip AD; Elschot M; Bult W; de Jong HW; Meulenhoff PC; Zonnenberg BA
    J Exp Clin Cancer Res; 2010 Jun; 29(1):70. PubMed ID: 20550679
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Holmium-166 radioembolisation in patients with unresectable, chemorefractory liver metastases (HEPAR trial): a phase 1, dose-escalation study.
    Smits ML; Nijsen JF; van den Bosch MA; Lam MG; Vente MA; Mali WP; van Het Schip AD; Zonnenberg BA
    Lancet Oncol; 2012 Oct; 13(10):1025-34. PubMed ID: 22920685
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.